Growth investing

Growth investing is an equity strategy built around companies expected to grow revenue and earnings faster than the market. You accept bigger swings and thin dividends in exchange for capital appreciation, and you hold the position for years, not for weeks.

The label describes an approach, not a security. A growth stock is the raw material — growth investing is what you do with a basket of them, and how long you sit still.

You’re buying tomorrow’s earnings at today’s price — paying a premium multiple upfront and sitting through drawdowns while the business compounds. A stalled thesis turns that premium into a capital loss fast.

Time horizon separates the strategy from speculation. A three-to-five-year hold lets compounding do the work. Trading the same names around earnings exposes you to gaps of 10–15% overnight, which is a different game.

Key takeaways

• Growth investing buys capital appreciation, not income, so most holdings pay little or no dividend.
• Portfolios run concentrated at the top and diversified in the tail, and that split is the real risk decision.
• The sector tilt leans technology, biotech and consumer internet, so every interest rate move reprices the book.
• It pairs with value investing and a bond sleeve to steady a portfolio across cycles.
• Concentration risk is real: Peloton lost about 78% of its value in 2022 and Zoom about 64%.

How it works

Growth investing works by concentrating capital in a handful of fast-compounding businesses, then holding long enough for earnings to grow into the multiple you paid. Position sizing, holding period and rebalancing decide more than stock picking does.

The screen itself is the easy part. Corporate Finance Institute defines a growth stock as one expected to outpace the average rate of market growth.

Most managers filter on revenue growth, earnings trajectory and return on invested capital, then stop. What happens after the screen is where the strategy actually lives.

Position sizing follows a barbell. Most growth funds concentrate 40–60% of assets in the top ten holdings, then spread the tail across 40–80 mid-cap names to catch the next winner early without single-name blow-up risk.

Turnover is the quiet variable. A fund that recycles its tail every year pays away part of the compounding it set out to capture, which is why many growth managers let winners run rather than trim back to target weight.

The style differs from its closest cousin on almost every axis.

Rotation is what catches people out. FTSE Russell’s June 2026 Russell reconstitution flagged fresh style shifts between the growth and value indexes.

That matters for allocation, not trivia. A stock can carry the growth label one year and the value label the next, so your asset allocation drifts even when you buy nothing.

Growth historically outperforms during low-rate expansions and lags when policy tightens. The 2022 selloff wiped 33% off the Nasdaq-100 in a single year as terminal-rate expectations climbed — the rate-sensitivity trade in its rawest form.

Every interest-rate decision reprices the distant cash flows growth buyers are paying for. The US Securities and Exchange Commission’s investor.gov guide to stocks covers the basics underneath both styles.

Examples

Real growth allocations run from mega-cap technology anchors to small biotech names that can move 40% on a single trial result. The examples below show the same strategy at opposite ends of the market, and what each end does to a portfolio.

The Magnificent Seven (Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla) drove a disproportionate share of S&P 500 returns through 2023 and 2024. That is why most large-cap growth funds look near identical at the top.

Here is what concentration costs. Put 60% of a growth sleeve in seven mega-caps and 40% across thirty smaller names: each big position is about 8.6% of the sleeve and each small one about 1.3%.

A 78% drawdown therefore costs you roughly 6.7% of the sleeve at the top and about 1% in the tail. That ratio, not the stock pick, is the decision you actually made.

Peloton and Zoom are the cautionary pair. Both looked like durable winners in 2021 before revenue normalised after the pandemic. Peloton lost about 78% of its value across 2022; Zoom lost about 64%.

A thesis can break faster than a multiple contracts, and a barbell only helps if the broken name sat in the tail. Both sat near the top in 2021.

Outside the US, ASML in the Netherlands and Novo Nordisk in Denmark rank among the best-performing global growth names of the last decade. Both compound through pricing power rather than volume.

Retail growth stories like Chipotle and Costco fit the profile too: high single-digit same-store sales growth and premium multiples that reward execution over five to ten years.

Biotech growth carries binary risk. Vertex Pharmaceuticals compounds quietly on approved-drug revenue, while smaller names live or die on phase-3 readouts — one failed endpoint can halve a market cap in a day.

For index exposure, the Vanguard Growth ETF (VUG) and the iShares Russell 1000 Growth ETF (IWF) hold the largest US growth names by market capitalisation.

Morningstar‘s Style Box, the three-by-three grid that sorts funds by size and by value-to-growth orientation, tells you where a fund actually sits rather than where its name suggests.

Related terms

The cluster around growth investing splits three ways: the rival style you balance it against, the security and income mechanics inside it, and the portfolio decisions that sit above it. Each bullet below marks one of those boundaries.

• Value Investing: buying companies trading below intrinsic value, the philosophical opposite of growth.
• Growth Stock: the individual security that populates a growth portfolio.
• Dividend: the cash payout most growth companies deliberately skip to fund expansion.
• Asset Allocation: the portfolio decision on how much capital sits in growth at all.
• Bond: the fixed-income counterweight most growth-heavy portfolios pair with for stability.
• Capital Loss: the realised downside when a thesis breaks and shares are sold below cost.
• Interest Rate: the policy variable that growth multiples track most closely.

FAQ

What is the main goal of growth investing?

Capital appreciation. Growth investors buy companies expected to grow earnings faster than the market and rely on rising share prices, not income, for their return.

How is growth investing different from value investing?

Growth investing pays a premium for future earnings and tolerates thin dividends. Value investing hunts shares trading below intrinsic worth, usually with higher yields and lower price-to-earnings ratios. Most balanced portfolios hold both, because leadership rotates.

Is growth investing riskier than other styles?

Yes, on average. Valuations are higher, so drawdowns during rate hikes or missed earnings cut deeper. Diversification across the tail and a multi-year horizon soften the swings without removing them.

Who should consider growth investing?

Investors with a long horizon, tolerance for volatility and no immediate need for portfolio income. It fits people still building wealth better than retirees drawing it down.

How do I start growth investing?

Start with a low-cost growth index fund for diversified exposure, then add single names only once you can write each company’s thesis in one paragraph. Size those positions before you buy, not after the first drawdown.

Do growth stocks pay dividends?

Most do not, because growth companies reinvest earnings into research, hiring and acquisitions rather than payouts.

Explore more investing and outsourcing terms across Outsource Accelerator.